Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia

NCT00671658 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Acute Lymphoblastic Leukemia

Interventions

DRUG: Rituximab
DRUG: Cyclophosphamide (CTX)
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Dexamethasone
DRUG: Methotrexate (MTX)
DRUG: Cytarabine
DRUG: G-CSF
DRUG: Mesna
DRUG: Pegylated asparaginase
DRUG: Pegfilgrastim
DRUG: Solumedrol

Sponsor

M.D. Anderson Cancer Center